Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Exposure to Hazardous Substances and Associated Disability: A Nationwide Eight-Year Study, 2018-2025

NCT07879261 is registered in ClinicalTrials.gov with Sergio Gabriel Susmallian as lead sponsor.

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, 14-day trial. Card required. Your first charge is when the trial ends. See pricing

Get the NCT07879261 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Follow this trial by email

Registry record

As filed in ClinicalTrials.gov.

Title
Exposure to Hazardous Substances and Associated Disability: A Nationwide Eight-Year Study, 2018-2025
Lead sponsor
Sergio Gabriel Susmallian
Phase
Observational
Overall status
Completed
Start date
January 1, 2018
Completion date
December 31, 2025
Enrollment
1,951 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

Arms

As registered; 1 arm.

  • Workers With Occupational Exposure to Hazardous Substances Retrospective Administrative Data Assessment

    Workers with occupational claims related to exposure to hazardous chemical substances and other non-solar hazardous agents recorded in the National Insurance Institute of Israel database between January 2018 and December 2025. The study includes administrative information on demographic characteristics, occupational exposure-related diagnoses, geographic distribution, medical assessments, temporary and permanent disability determinations, assigned disability severity, and compensation classifications. Solar and sunlight-related conditions are excluded from the diagnostic analysis. All data were collected retrospectively from existing administrative records.

Primary endpoints

Registered primary outcome measures; 1 primary.

  • Occupational Hazardous Substance-Exposure Claim Rate January 1, 2018, through December 31, 2025

    Annual number of recognized occupational hazardous substance-exposure claims per 100,000 employed persons in Israel. Rates will be calculated using annual claim counts and the average national employed population. Temporal trends will be evaluated across the study period using regression models with appropriate denominator offsets. The outcome is an administrative claim rate rather than the incidence of occupational disease or exposure.

Lead sponsor's other trials

Sergio Gabriel Susmallian, most recent start first.

Similar trials

Same condition (Dermatitis, Contact) and phase, most recent start first.